Company Summary:

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Seres Therapeutics (NASDAQ:MCRB), Moderna (MRNA), Syros Pharmaceuticals (SYRS), Rubius Therapeutics (RUBY), Axcella Health, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary:

The Sr. Research Associate will be primarily responsible for designing and synthesizing new gene therapy technology. This individual will join a dynamic, rapidly growing, and highly collaborative team that combines significant biologic drug discovery experience with pioneering discoveries driving a novel biological platform.

Responsibilities:

• Production of DNA plasmids, including Gibson and Golden Gate assembly
• Bacterial culture, cloning, transformation, and Sanger sequencing confirmation
• Design, execution, and troubleshooting of experiments as well as data analysis
• Performs research and/or development in collaboration with others
• Makes detailed observations, analyzes data and interprets results
• Exercises technical discretion in the design, execution and interpretation of experiments that contribute to project goals
• Prepares technical reports, summaries, protocols, and quantitative analyses.
• Investigates, creates and develops new methods and technologies for project advancement
• Maintains high level of professional expertise through familiarity with scientific literature and novel technologies

Preferred Qualifications (one or more):

• Design, synthesis, and testing of DNA constructs
• Experience with Gibson and/or Golden Gate assembly
• Experience with molecular biology techniques

Basic Qualifications:

• M.S. or B.S. in Biochemistry, Chemistry, Chemical Biology, or related field.
• 2+ years of industry experience is preferred.
• A strong self-starter, independent thinker, with a strong attention to detail.
• Demonstrated industry experience or academic achievement, as evidenced by publications in high impact journals or drug development is required
• Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner.
• Eager to work with highly-skilled and dynamic teams in a fast-paced, entrepreneurial and technical setting.
• Confident, execution focused, team oriented, with an ability to thrive in an entrepreneurial environment.

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies:  Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates.  The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team.   Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.